IngredientsEpigaea repens, commonly known as the mayflower, trailing arbutus, or ground laurel, is a low and spreading shrub in the family Ericaceae. The scientific name, coined by Carl Linnaeus in 1753 from Greek and Latin, literally means "creeping (or running) on the earth." More specifically, the genus name Epigaea is said to come from a Greek phrase meaning "upon the earth," referring to the trailing growth of the plant, while the species name repens refers to the fact that the plant has creeping and rooting stems.
Epigaea repens belongs to the cosmopolitan Heath Family, Ericaceae, which comprises about 100 genera and 3,000 species, mostly shrubs. Two botanical varieties are recognized: the nominate variety and the variety glabrifolia Fern., which ranges northward from the higher parts of the Appalachian Mountains to Newfoundland, Nova Scotia, and Labrador and west to Saskatchewan.
Common names include: Trailing arbutus, Winter-pink, Gravel-weed, Gravel plant, Mountain-pink, Ground laurel, May-flower. Other common names for Trailing Arbutus include Mayflower, Ground Laurel, Shadflower, Winter Pink, and Plymouth Mayflower — the latter name apparently referring to the idea that the plant heralded spring for the winter-weary Pilgrims in colonial America.
The plant is a slow-growing, prostrate to sprawling shrub that prefers moist, shady habitats and acidic (humus-rich) soil. These very low-growing plants, technically subshrubs, are 4–6 inches (10–15 cm) high, and among the first to bloom in the spring, spreading to widths of about 2 feet (60 cm). Its stems are woody and the leafy twigs are covered in rust-colored hairs; the leaves are alternate, ovate (oval-shaped with rounded bases), evergreen, glabrous above and more or less hairy beneath, and borne on short rusty-hairy petioles. The flowers are pentamerous, pale pink to nearly white and very fragrant, about 0.5 inches (1.3 cm) across when expanded, and borne in clusters at the ends of the branches. Fruits are berries that are yellowish-orange, with white interiors, about 1/8 inch (5 mm) in diameter.
Trailing arbutus is an evergreen, prostrate, creeping shrub that grows in patches up to 60 cm in diameter; it is found growing in woodlands on acid, sandy soils from Florida to Mississippi, north to New England, southeast to New York, Pennsylvania, West Virginia, and Ohio. Trailing arbutus thrives best in association with mycorrhizal fungi.
The parts that grow above the ground are used to make medicine. Historically, the leaves are evergreen, alternate, cordate-ovate, entire, 2 or 2½ inches long, by 1½ wide and constitute the primary medicinal plant part documented in both traditional and Eclectic sources. The leaves can be used fresh or can be harvested in the summer and dried for later use.
Trailing arbutus has historically been prepared in several distinct forms:
Trailing arbutus has a well-documented tradition of use among multiple Indigenous peoples of eastern North America, recorded in ethnobotanical literature. These traditional practices are documented in 19th- and 20th-century ethnobotanical records, such as those compiled in Native American Ethnobotany by Daniel E. Moerman (1998), drawing from field studies and oral histories.
Specific tribal uses include:
Early European settlers adopted similar uses, preparing leaf teas for kidney and urinary ailments, while the fragrant flowers were harvested post-colonization for incorporation into perfumes and soaps due to their spicy, sweet scent.
The name "Gravel Plant" derives from its use in purging kidney stones; it was sold as a folk remedy for this purpose by the Shakers religious sect.
Trailing arbutus became a significant remedy in 19th-century Eclectic medicine, a North American movement that drew heavily on indigenous and folk botanical knowledge. The American Eclectic Dispensatory of 1854 described it as "a very valuable Eclectic remedy, highly beneficial in gravel, and all diseases of the urinary organs; superior to uva ursi, or foreign buchu, and where these have failed in producing benefit, this has succeeded."
King's American Dispensatory (1898) recorded that trailing arbutus specifically influences the urinary organs, is diuretic and astringent, and is highly beneficial in lithic acid gravel, and all diseases of the urinary organs attended with vesical irritation. It was said to render the urine less irritating, and was of value to control vesical tenesmus, dysuria, and strangury.
The Eclectic physician Ellingwood elaborated the symptom picture for which the plant was indicated: the agent was recommended for use where there was excess of uric acid, where the "brick dust" deposit was marked, where renal sand or gravel was present in the bladder, where the urine was dark and heavy causing irritation and congestion of the kidneys, and where precipitated solids irritated the bladder inducing cystitis with thickening of the walls and formation of pus.
In addition to its influence upon the kidneys, epigaea was noted as a carminative of much value, and as a stomach tonic that soothes gastric irritation. It was also occasionally used with advantage in diarrhea and bowel complaints of children.
In the 1920s, Epigaea repens was gathered and sold in bunches for as much as $25 a day; unfortunately the plant grows slowly and often did not recover from exploitation, leading one commentator of the time to warn of potential eradication from many known locations.
The phytochemical analysis of Epigaea repens documented in historical pharmaceutical sources identifies the following compounds in the leaves:
Phytochemical analysis identified the glucoside arbutin (C₁₂H₁₆O₇), urson (C₂₀H₃₂O₂), and the very bitter glucoside ericolin (C₃₄H₅₆O₂₁, or according to Thal C₂₆H₃₀O₃), as well as formic acid. Grape sugar, gum, and coloring matter were found in addition to these constituents. Other identified constituents include gallic acid and tannin.
These constituents closely parallel those of the related Ericaceae species bearberry (Arctostaphylos uva-ursi). Epigaea repens contains arbutin and has been proposed as a substitute for bearberry in herbal use.
Arbutin (4-hydroxyphenyl-β-D-glucopyranoside), the β-glucoside of hydroquinone, is present in several plants and has mainly an antiseptic action on the urinary tract.
Arbutin (hydroquinone β-D-glucoside) is a compound of plant origin possessing valuable therapeutic (urinary tract disinfection) and cosmetic (skin whitening) properties.
Arbutin is generally present in plants in combination with methylarbutin, especially in those belonging to the Ericaceae family.
Arbutin is absorbed from the gastrointestinal tract where it begins to split into aglycone hydroquinone and glucose by intestinal microflora under the influence of the enzyme β-glucosidase; the antimicrobial effect of arbutin is directly dependent on β-glucosidase activity.
Arbutin is absorbed from the gastrointestinal tract, metabolized to glucuronide in the liver, and hydrolyzed during renal excretion to form the active compound hydroquinone, which is believed to have local antiseptic activity on the urinary mucous membrane.
Hydroquinone is recognized as an active substance at the site of action (urinary tract) and it may be important for the therapeutic activity of a herbal preparation.
Beyond urinary antisepsis, arbutin has additional documented mechanisms: its skin-lightening mechanism of action involves inhibiting the activity of tyrosinase, an essential enzyme for melanin synthesis in human skin. Arbutin has a variety of potentially pharmacological properties, including anti-inflammatory, antihyperlipidemic, antiviral, antihyperglycemic, and antioxidant activity.
The leaves of Epigaea repens are described as astringent, diuretic, and tonic. The presence of gallic acid and tannins identified in historical analyses accounts for the astringent properties attributed to the plant. The tannin content is relevant to both the therapeutic astringency on urinary mucous membranes and to potential gastrointestinal effects with high-dose or prolonged use.
Ericolin, a bitter glycoside also found in bearberry, and urson (a triterpenoid also called uvaol or ursolic acid in related nomenclature in the Ericaceae family) are recorded constituents of the leaves. These are shared with other Ericaceae species used in urinary herbal medicine, though their specific contributions to the pharmacological activity of Epigaea repens have not been studied separately in modern research.
Traditional and historical evidence base: The urinary applications of trailing arbutus have the strongest documentary basis, rooted in multiple independent traditions (several Indigenous peoples, the Shakers, and the 19th-century Eclectic movement). Trailing arbutus was said to specifically influence the urinary organs — diuretic and astringent — and was considered highly beneficial in lithic acid gravel and all diseases of the urinary organs attended with vesical irritation, with some Eclectic authorities claiming it superior to uva ursi or foreign buchu.
Proposed mechanism (arbutin pathway): Traditional application of arbutin was mainly related to its antiseptic and diuretic activity for treating urinary tract infections or cystitis and kidney stones.
State of modern clinical evidence: More evidence is needed to rate the effectiveness of trailing arbutus for these uses. No modern clinical trials validate these uses. While clinical evidence exists for the arbutin-containing related species Arctostaphylos uva-ursi in urinary tract infections, no independent human clinical trials have been conducted specifically on Epigaea repens preparations. The mechanistic plausibility rests on the shared arbutin content, but the actual arbutin concentration in Epigaea repens leaves has not been quantified in peer-reviewed studies, and no pharmacokinetic data specific to this species have been published.
Evidence strength: Weak. Traditional use is extensive and cross-cultural, and the proposed arbutin mechanism is pharmacologically plausible based on data from related species, but no human clinical trial or controlled study specific to Epigaea repens has been identified in the peer-reviewed literature.
Historical and ethnobotanical records document use for a range of digestive complaints. Epigaea was noted as a carminative of much value, functioning as a stomach tonic that soothes gastric irritation. The Algonquin used an infusion of leaves for kidney disorders; the Cherokee used a decoction of the plant to induce vomiting to treat abdominal pain and gave an infusion of the plant to children for diarrhea.
Evidence strength: Exclusively traditional and historical. No modern preclinical or clinical data specific to Epigaea repens for gastrointestinal outcomes exist in the peer-reviewed literature.
The Iroquois used a compound decoction for rheumatism. No modern pharmacological or clinical studies have investigated Epigaea repens for anti-inflammatory or antirheumatic effects. The broader anti-inflammatory properties of arbutin have been investigated in other contexts, but extrapolating this to Epigaea repens specifically is not supported by direct evidence.
Evidence strength: Traditional use only; no modern experimental or clinical data for Epigaea repens in this indication.
The Iroquois also used a compound for labor pains in parturition. No modern pharmacological investigation of this use is documented.
Evidence strength: Single ethnobotanical record; no supporting pharmacological or clinical data.
Since arbutin is a shared constituent across the Ericaceae family, the following summary applies to arbutin as a compound rather than to Epigaea repens specifically, and should not be treated as evidence for the herb itself:
These findings pertain to arbutin as an isolated compound or to preparations of Arctostaphylos uva-ursi and should not be directly transferred as evidence of efficacy for Epigaea repens preparations until the arbutin content of E. repens leaves is independently characterized and bioavailability is confirmed.
Based on documented traditional, historical, and proposed pharmacological information, the following body systems and health areas have been associated with Epigaea repens:
No modern clinical trials have established evidence-based dosing guidelines for Epigaea repens. The following dosages are those reported in 19th-century Eclectic pharmaceutical literature and are presented solely as historical records:
It is important to note that these dosages were formulated within a 19th-century Eclectic pharmaceutical framework and have not been evaluated in controlled settings. No modern standardized extract or dosage form for Epigaea repens has been validated through clinical research.
The primary safety concern with Epigaea repens is the metabolic fate of its principal constituent, arbutin. The plant contains arbutin and, although this is an effective urinary disinfectant, it hydrolyzes to hydroquinone which is toxic.
The use of arbutin causes dermatitis rarely, and caution is recommended for the use of arbutin-containing products, especially from the viewpoint that hydroquinone may be generated during product use.
Trailing arbutus seems to be safe when used short-term; however, long-term use can lead to poisoning.
Caution is advised due to potential toxicity from high tannin levels, which can cause gastrointestinal upset, and from arbutin, which metabolizes to hydroquinone, a compound linked to adverse effects in excessive doses.
Plants are reported as poisonous to some livestock, and may be to people as well.
No controlled safety studies, pharmacokinetic studies, drug interaction assessments, or reproductive toxicology studies specific to Epigaea repens preparations have been identified in the peer-reviewed scientific literature. The safety inferences that exist are extrapolated from data on arbutin and structurally related Ericaceae species.
Historical overharvesting for medicinal and ornamental purposes has contributed to population declines in some regions. Digging up one in Massachusetts is punishable with a $50 fine, reflecting the plant's protected status as the state's floral emblem. The plant appears to be sensitive to abrupt environmental disturbances, such as lumbering and grazing, which may account for its present scarcity, and it is difficult to cultivate. Wildcrafting of this species therefore carries ecological as well as safety considerations.
It is important not to confuse trailing arbutus with another plant called gravel root (Eutrochium purpureum, a member of the Asteraceae family), which shares a common folk name but is botanically and pharmacologically distinct.
Epigaea repens is the floral emblem of both Nova Scotia and Massachusetts. In Nova Scotia, it was designated the provincial flower in 1901, selected for its early spring emergence as a symbol of resilience amid lingering cold. It was designated the State plant of Massachusetts in 1918.
In New England and elsewhere, the common name is "Mayflower," a name said to date to the Pilgrims, who found it abundant around Plymouth, Massachusetts, and regarded the first bloom as assurance that their first terrible winter was over.
Health conditions that Trailing arbutus may help support.
Body systems that Trailing arbutus may help support.
Go back